![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605762178.jpg\")
<\/p>\n<\/p>\n
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers<\/em><\/p>\n Roots Analysis<\/a> is pleased to announce the publication of its recent study, titled, \u201cHPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030<\/a>.\u201d<\/p>\n The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of HPAPIs and cytotoxic drugs. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. In addition to other elements, the study includes:<\/p>\n Type of Product<\/p>\n Company Size<\/p>\n Scale of Operation<\/p>\n Type of Pharmacological Molecule<\/p>\n Type of Highly Potent Finished Dosage Form<\/p>\n Key geographical regions<\/p>\n The report includes detailed transcripts of discussions held with the following senior level representatives of stakeholder companies:<\/p>\n Key companies covered in the report<\/a><\/p>\n For more information please click on the following link:<\/p>\n https:\/\/www.rootsanalysis.com\/reports\/view_document\/hpapi-and-cytotoxic-drugs-manufacturing\/299.html<\/a><\/p>\n Other Recent Offerings<\/strong><\/p>\n About Roots Analysis<\/strong><\/p>\n Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you\u2019d like help with your growing business needs, get in touch at info@rootsanalysis.com<\/p>\n Contact Information<\/strong><\/p>\n Roots Analysis Private Limited<\/p>\n Gaurav Chaudhary<\/p>\n +1 (415) 800 3415<\/p>\n gaurav.chaudhary@rootsanalysis.com<\/p>\n Tags: Cytotoxic Drugs<\/a>, HPAPI<\/a>, Roots Analysis<\/a>, contract manufacturing<\/a>, biotech<\/a>, Analysis<\/a>, pharma<\/a>, report<\/a><\/p>\n Roots Analysis Tags:<\/b> Contact: Roots Analysis\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
See Campaign: <\/strong>https:\/\/www.rootsanalysis.com\/reports\/view_document\/hpapi-and-cytotoxic-drugs-manufacturing\/299.html<\/a>
Contact Information:<\/b>
Contact:
\nGaurav Chaudhary
\ngaurav.chaudhary@rootsanalysis.com<\/p>\n
\nA430, 4th Floor,
\nBestech Business Towers, Sector 66, Mohali, India
\nsales@rootsanalysis.com
\n+1 (415) 800 3415
\n+44 (122) 391 1091
\nWeb: https:\/\/www.rootsanalysis.com\/
\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis
\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n
<\/a>, Reportedtimes<\/a>, IPS<\/a>, iCN Internal Distribution<\/a>, Extended Distribution<\/a>, Wire<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nGaurav Chaudhary
\ngaurav.chaudhary@rootsanalysis.com<\/p>\n
\nA430, 4th Floor,
\nBestech Business Towers, Sector 66, Mohali, India
\nsales@rootsanalysis.com
\n+1 (415) 800 3415
\n+44 (122) 391 1091
\nWeb: https:\/\/www.rootsanalysis.com\/
\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis
\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.” The report features an extensive study of the current market landscape … Continue reading Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis<\/span><\/a> Continue Reading